been trying to characterize all of the polypeptides specific to vanadocytes and to specify the proteins that participate in the accumulation and reduction of vanadium. To date, we have localized three enzymes in vanadocytes: 6-phosphogluconate dehydrogenase (6-PGDH: EC 1.1.1.44), glucose-6-phosphate dehydrogenase (G6PDH: EC 1.1.1.49), and glycogen phosphorylase (GP: EC 2.4.1.1), all of which are involved in the pentose phosphate pathway.
In the current study, we cloned a cDNA for transketolase, an essential and ratelimiting enzyme in the non-oxidative part of the pentose phosphate pathway, from vanadocytes. The cDNA encoded a protein of 624 amino acids, which showed 61.8% identity to the human adult-type transketolase gene product. By immunocytochemistry and immunoblot analyses, the transketolase was revealed to be a protein that was expressed only in vanadocytes and not in any of the more than ten other types of blood cell. This finding, taken together with the localized expression of the other three enzymes, strongly supports the hypothesis that the pentose phosphate pathway functions exclusively in vanadocytes.
1.Introduction
Ascidians, known as tunicates or sea squirts (Chordata, Urochordata, Ascidiacea), accumulate extremely high levels of vanadium in vanadocytes, one
of their approximately ten types of blood cell [1] [2] [3] [4] [5] . The vanadium concentration in vanadocytes can reach 350 mM, corresponding to 10 7 times the level in seawater, where vanadium is dissolved at a concentration of 35 nM [6, 7] . This is thought to be the highest rate of concentration of a metal in any living organisms. Vanadium, a multivalent transition metal, is generally present in the biosphere in the +5, +4, and +3 oxidation states [8, 9] . Vanadium dissolved in seawater usually occurs as vanadate anions in the +5 oxidation state (V(V)) [10] , whereas most vanadium in vanadocytes is reduced to the +3 oxidation state (V(III)) with a small amount in the +4 oxidation state (V(IV)) [11] [12] [13] [14] [15] [16] [17] . Some reducing agents must, therefore, be involved in the reduction and accumulation of vanadium in ascidian blood cells. In vitro experiments have shown that some biologically relevant reducing agents can reduce V(V) to V(IV), including ascorbate [18] , cysteine [19, 20] , norepinephrine [21] , and glutathione [22] .
However, no information has been obtained on the reducing agents that participate in the reduction in ascidian vanadocytes.
About ten years ago, we prepared several monoclonal antibodies to distinguish vanadocytes from the other types of blood cell. During the course of these experiments, a monoclonal antibody, S4D5, recognized a 45 kDa antigen specific to the cytoplasm of vanadocytes [23] . This was revealed to be 6-phosphogluconate dehydrogenase (6-PGDH: EC1.1.1.44) based on cDNA isolation of RNA samples from the blood cells of the ascidian by immunoscreening [24] .
6-PGDH from the pentose phosphate pathway is localized massively in vanadocytes. Therefore, we examined whether other enzymes related to the pentose phosphate pathway are also localized in vanadocytes. As a result, two other enzymes related to the pentose phosphate pathway were also revealed to be exclusively and strongly expressed in vanadocytes by immunocytochemistry and by measuring enzymatic activity [25, 26] . One is glucose-6-phosphate dehydrogenase (G6PDH: EC1. 
Preparation of anti-transketolase antiserum
The partial fragment of ascidian transketolase cDNA that corresponded to the amino acid residues from the 27 th to the 264 th residue ( One hundred micrograms of purified TKT-MBP fusion proteins were injected intraperitoneally into an 8-week-old female BALB/c mouse. The injection was repeated two and four weeks after the first injection. Three days after the last injection, blood was collected, allowed to stand at 37°C for 1 hr, and incubated at 4°C for 12 hrs. The serum was removed from the clot, and any remaining insoluble material was removed by centrifugation at 10,000 ×g for 10 min at 4°C. The supernatant obtained was stored at -20°C.
Immunoblotting and immunohistochemistry
Immunoblot analysis and immunocytochemistry with anti-transketolase 7 antiserum were carried out as described previously (19, 20) . Briefly, the TKT-MBP fusion proteins were electrophoresed and blotted onto a nitrocellulose membrane. The antibodies were purified with the immobilized fusion proteins.
The purified antibodies were used for both the immunoblot analysis and the immunocytochemistry at 4,000 and 1,000 times dilution calculated from the original antiserum, respectively. sydneiensis samea blood cells. They contained almost identical nucleotide sequences, although their lengths varied from 1.1 kbp to 2.5 kbp. We chose the longest cDNA clone, #106, subcloned it by restriction digestion, and sequenced both strands of the subclones completely (Fig. 1) . The nucleotide length of cDNA clone #106 was 2,545 bp including the cloning sites (EcoRI at the 5'
terminal and XhoI at the 3' terminal). This is consistent with the apparent length of the transcript detected by Northern blot analyses (data not shown),
suggesting that the cDNA clone corresponded to full-length mRNAs. The cDNA contained a single, long open reading frame of 1,875 nucleotides including the termination codon, which encoded a protein of 624 amino acids (Fig. 1) .
The deduced amino acid sequence of ascidian cDNA clone #106 showed striking similarities to transketolases from various organisms (Fig. 2) . There was 61.8% amino acid identity between the ascidian and human adult-type transketolase sequences, and 61.7% identity between the ascidian and mouse transketolase sequences. A thiamine diphosphate-binding motif and a transketolase motif, which were pointed out by Schenk et al. (23) , were found in the predicted amino acid sequence of cDNA clone #106 (Fig. 2) . Within the transketolase motif, an NADH-binding-like motif was also completely conserved (Fig. 2) . The calculated molecular weight of the amino acid sequence predicted from cDNA clone #106 was 67.8 kDa, which is close to those of mammals (ranging from 67.7 to 67.8 kDa) and a nematode (66.0 kDa). Therefore, we concluded that cDNA clone #106 corresponded to a transketolase homologue in A. sydneiensis samea.
Expression of transketolase proteins in vanadocytes 9
More than ten types of blood cell have been distinguished in A.
sydneiensis samea on the basis of their morphology. These include hemoblasts, lymphocytes, leukocytes, pigment cells, morula cells, signet ring cells, compartment cells, small compartment cells, and giant cells [27] [28] [29] [30] . Of these, signet ring cells have been revealed to be the vanadium-accumulating cells, also known as vanadocytes, and these generally account for more than 70% of the total blood cells [29, 31, 32] . To examine the localization of transketolase, we 
Discussion
The first clue to the exclusive localization of enzymes in the pentose phosphate pathway in vanadocytes was the identification of monoclonal antibody S4D5, which was prepared to distinguish vanadocytes from the approximately ten types of ascidian blood cell [23] . A 45-kDa antigen, recognized by S4D5 monoclonal antibody, was found to localize in the cytoplasm of vanadocytes and produce a clear band on SDS-PAGE of the homogenate of ascidian blood cells.
The antigen was unexpectedly revealed to be 6-PGDH [24] , which is generally thought to be expressed ubiquitously. The specific expression of glucose-6-phosphate dehydrogenase (G6PDH), another enzyme in the pentose phosphate pathway, in the cytoplasm of vanadocytes, has also been detected by both immunocytochemistry and enzymatic activity [25] . Furthermore, a 100 kDa antigen recognized by a newly prepared monoclonal antibody, S8E4, was exclusively localized in the cytoplasm of vanadocytes and identified as glycogen phosphorylase (GP), by sequencing the encoded cDNA [26] . The fact that glycogen phosphorylase and three other enzymes in the pentose phosphate pathway, including TKT found in this study, are abundant in the cytoplasm of vanadocytes, while undetectable in the other blood cells, suggests that the pentose phosphate pathway is closely linked with the reduction and accumulation of vanadium ions in vanadocytes.
Most of the vanadium accumulated in ascidians is reduced to V(III), with a small amount of vanadium also present as V(IV) [12] [13] [14] [15] [16] [17] . A consensus has been reached on the process of vanadium accumulation in ascidians. First, vanadium dissolved in seawater as V(V) is accumulated in ascidians. Then, the vanadium is reduced to V(IV) by some reducing agent contained in the ascidians.
Finally, almost all the vanadium is accumulated in the vacuoles of vanadocytes in the cationic form of V(III) under high sulfate concentrations at an extremely low pH [32] [33] [34] [35] . In the vacuoles, the vanadium seems to be in a free form and not bound to macromolecules.
Thus, the pentose phosphate pathway is the major supplier of reducing agents in the form of NADPH, and is tightly coupled to cellular processes that require NADPH and other reductase systems. In fact, we have confirmed that NADPH directly reduces V(V) to V(IV) in vitro, in the presence of EDTA at neutral pH [36] . It is important to consider whether the reduction of V(V) observed in vitro occurs in vivo. It is reasonable to assume that V(V) ion binds to a peptide or protein in the cytoplasm of ascidian vanadocytes. We have isolated a vanadium-associated protein that is composed of at least 12.5 and 15 kDa peptides from vanadocytes [37] and cloned the cDNA encoding these TKT is known to be a rate-limiting enzyme of the pentose phosphate pathway. Although essentially most types of cell in all organisms examined have this enzyme, its expression is regulated in accordance with its requirement.
For example, transketolase activity in human white blood cells is extremely high, and a loss of its activity occurs in several diseases, such as a chronic lymphatic leucemia [38] . The activity is 100-200 times higher than that of red blood cells, suggesting the specific localization and function of pentose phosphate pathway in white blood cells. Another example is that the mammalian cornea contains particularly high levels of TKT, consistent with the proposal that NADPH produced by the pentose phosphate pathway activity has a role in the removal of light-generated radicals [39] [40] [41] [42] . Therefore, in ascidian vanadocytes, the specific expression of TKT suggests an requirement for NADPH to reduce V(V) to V(IV).
As shown schematically in Fig. 5 , we have identified several proteins specific to vanadocytes. Two polypeptides, of 58 and 45 kDa, have been identified as G6PDH and 6-PGDH, respectively [24, 25] . A 100 kDa protein has been identified as GP [26] . In addition, this study found that TKT in the pentose phosphate pathway was exclusively expressed in vanadocytes. The localization of these enzymes strongly supports the hypothesis that the pentose phosphate pathway functions in vanadocytes and generates NADPH, which may be used as a reducing agent during the course of vanadium accumulation. On the other hand, smaller molecules of 12.5, 15, and 16 kDa were identified as vanadium-associated proteins (VAPs) [37] . Their characterization is on going.
The vanadium ions are accumulated in the vacuoles of vanadocytes, where protons and sulfate ions at extremely high concentration coexist with V(III) ions.
We have already identified and cloned several subunits of a vacuolar-type proton
ATPase localized in the vanadocytes [43, 44] , and a search for other subunits and other membrane proteins is in progress.
The exclusive presence of these peptides in vanadocytes has attracted our attention and must be the key to elucidating the mechanism of the unusual ascidian ability to accumulate vanadium at extremely high levels, which has never been reported in other living organisms, and reduce it to V(III).
The function of the accumulated vanadium ions in the ascidian still remains to be explained. Several researchers proposed that the vanadocytes use vanadium ions for the synthesis of tunic [48] [49] [50] [51] [52] [53] , while others proposed that the vanadium-containing vanadocytes may trap oxygen [54] . Another hypothesis is proposed that vanadium ions may be used as antimicrobial agents [55] [56] .
However, these proposals are not supported by sufficient experimental evidences.
Figure Legends (Homo sapiens), adult-type isoform [45] ; MM, mouse (Mus musculus) [46] ; As, ascidian (Ascidia sydneiensis samea) (this study); CE, nematode (Caenorhabditis elegans) [47] . 
